Home Newsfeeds Guggenheim Upgrades Teladoc Health to Neutral

Guggenheim Upgrades Teladoc Health to Neutral

Guggenheim analyst Sandy Draper upgrades Teladoc Health (NYSE:TDOC) from Sell to Neutral.

byBenzinga Newsdesk

October 24, 2022

1 minute read

Guggenheim analyst Sandy Draper upgrades Teladoc Health (NYSE:TDOC) from Sell to Neutral.

Inozyme Pharma Highlights Inclusion Of Generalized Arterial Calcification Of Infancy In Genomics England’s Generation Study Of Rare Conditions

By Benzinga Newsdesk

October 10, 8:35 AM

Inozyme Pharma, Inc. (NASDAQ:INZY) ("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal

INZY

News

‘Japan Approves Plan To Open Its First Casino’ – BBC

By Happy Mohamed

April 14, 2:20 PM

https://www.bbc.com/news/business-65271857 Japanese officials have approved controversial plans to build the country's first gambling resort. The complex will open in the western city of Osaka in 2029. Casinos

EWJ

Reported Late Monday, Obsidian Energy Sees 32,000-33,500 boe/d In 2023 And Significant 2022 Reserves Value Increase With Year-End Reserves Report; Q4 Capital Was ~$97M, Bringing Full Year Capital Slightly Below Our 2022 Guidance At $319M

By Happy Mohamed

January 31, 1:35 AM

2023 GUIDANCE With a strong start to our 2023 development program, Obsidian Energy expects to grow average production to approximately 32,000 to 33,500 boe/d in 2023 - a seven percent increase from 2022 at the

OBE